This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this role, he spearheads the development and implementation of innovative wellness strategies across Banyan Groups diverse portfolio of luxury resorts, spas, and wellbeing experiences. PH: As Director of Integrated Wellbeing, I lead the strategic vision and execution of the Groups wellbeing portfolio.
The company has appointed Alex Haskell, MBA, as Vice President of Marketing, Sean Mathison as Vice President of Business Development & Innovation, Jonathan Nugent as Sales Director, and Olivia Swanson as Sales Director. Jonathan Nugent, Sales Director Mr. Nugent’s career includes roles at Medicis and Colgate-Palmolive.
The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.
Upon close, Cosette will market 12 patent-protected products focused on womens health and dermatology, including leading brands such as Rhofade (oxymetazoline topical)and several programs in clinical development. Together, we will extend the reach of important therapies, drive innovation, and improve patient access.
Combined company’s flagship brands to include daxibotulinumtoxinA (Daxxify), the RHA filler Collection, SkinPen, PanOxyl, Blue Lizard, and StriVectin. “Revance has an impressive track record in developing innovative aesthetics offerings that will complement Crown’s innovative line of skincare products. .
Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces. LEMI’s versatile tables, for example, exemplify this innovation, offering multifunctionality that adapts to small spa environments.
Al-Masri has worked across branding, strategy, development, design, pre-opening, and ongoing operational management. Before her time at Equinox, she served as the Global Director of Spa Development and Operations at Starwood Hotel & Resorts, managing the company’s spa brands, partnerships, and a global portfolio of over 450 spas.
The creation of this new role affirms Auberge’s commitment to offering guests impactful wellness experiences and building innovative spas and wellbeing destinations. As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio.
The Group recently created the brand new role to solidify a renewed focus on wellness. During the last two decades she was based in southeast Asia, first with Hyatt International Hotels & Resorts and then with Rosewood Hotel Group – where she was responsible for the strategic development of wellness and brand experience.
Book4Time grew its global footprint, in part, through relationships with global hotel and resort brands; integrations with more than 60 technology providers, including property management systems (PMS) and point-of-sale systems (POS); and its highly efficient remote implementation, training and support capabilities.
Montage International encompasses the ultra-luxury brand Montage Hotels & Resorts, the luxury brand Pendry Hotels & Resorts, Montage Residences, Pendry Residences and the management of some premier golf courses and clubs. Prior to working with Montage, she worked as a Spa Director with Ritz Carlton.
Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. s global brand, where she oversaw product development, media strategies, digital initiatives and integrated marketing efforts, while championing digital equity strategies.
Hilton’s 2025 Trends Report unveils the rising travel trends predicted to ignite conversation and innovation while reshaping the travel experience in 2025. These findings highlight new opportunities for us to innovate across our global portfolio and further enhance guests’ stays.
Shiseido to Acquire Dr. Dennis Gross Skincare Shiseido Americas Corporation is set to acquire the Dr. Dennis Gross Skincare brand. With the addition of Dr. Dennis Gross Skincare, Shiseido seeks to accelerate and strengthen its core prestige skincare business which includes brands SHISEIDO and Clé de Peau Beauté.
“These formulations enhance overall skin texture, underscoring our commitment to integrating cutting-edge scientific research and ingredients into practical, effective skincare solutions,” says Eman Kadhim, Head of Scientific Communications & Upstream Innovation at Waldencast, in a news release.
In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I Obagi has been connected to our brand, in various capacities, since its inception. Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director.
At Spa Executive and Book4Time, we have had the opportunity to gather insights from leaders at the top luxury hotel & resort spa brands in the world – and asked a great many of them about what makes the best guest and wellness experiences. Design is a core focus for Jumeirah which also extends within the wellness spaces in the portfolio.
The company has a service-oriented approach to support brands in launching safe and compliant products on the markets. The company has a service-oriented approach to support brands in launching safe and compliant products on the markets. Dr M has over 20 years of experience in the pharmaceutical, biopharma and cosmetics industries.
and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. Evolus, Inc. This marks the second agreement Evolus has made with Symatese this year. to now include the U.K.
and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. Evolus, Inc. This marks the second agreement Evolus has made with Symatese this year. to now include the U.K.
Remington Hospitality, established in 1968, is a premier hotel management company renowned for its innovative and owner-centric approach. Managing an extensive portfolio of more than 120 hotels, including 26 major brands and 19 boutique properties, Remington has positioned itself as a leader in the hospitality industry.
Through her science education work, Michelle has worked with a range of brands on campaigns, including Proctor & Gamble and Johnson & Johnson. His current focus is on Sun care, Color cosmetics and Sustainable innovation. Her work has been featured in international magazines including Elle and Huffington Post.
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announced today that Carragelose inactivates the new, rapidly spreading variants and SARS-CoV-2 wildtype with similar efficacy in vitro.
This milestone represents an exciting new chapter in our long-term strategy to expand our portfolio and transition from a single-product company to a multi-product innovator, strengthening our leadership in performance beauty, says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content